Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05283642
Other study ID # DCI_GYN22
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 8, 2022
Est. completion date December 20, 2022

Study information

Verified date March 2022
Source Lo.Li.Pharma s.r.l
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Investigation of the effects of D-chiro-inositol supplementation in women with altered endometrial thickness.


Recruitment information / eligibility

Status Completed
Enrollment 13
Est. completion date December 20, 2022
Est. primary completion date October 29, 2022
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - altered endometrial thickness Exclusion Criteria: - patients with cancer - patients under hormonal treatments (progestogens and/or estrogens) - patients supplemented with inositols

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
DCI
Oral supplementation with D-chiro-inositol once daily

Locations

Country Name City State
Italy ASL Umbria 2 Terni Umbria

Sponsors (1)

Lead Sponsor Collaborator
Lo.Li.Pharma s.r.l

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in endometrial thickness Change in endometrial thickness by ultrasound measurement from baseline to three months Two time points: baseline and after three months
See also
  Status Clinical Trial Phase
Recruiting NCT05001282 - A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRĪ±) Phase 1/Phase 2
Recruiting NCT04145518 - Mechanistic Characterization of Uterine Pain Phase 4
Recruiting NCT03756480 - Cancer Driving Mutations in Endometriosis Lesions and Development of Progesterone Resistance
Recruiting NCT03748238 - Endometrial Injury In Recurrent Implantation Failure N/A
Completed NCT03519763 - Intrauterine Microbiota During IVF in Patients Affected With Isthmocele.
Completed NCT03207074 - Can the iKnife Distinguish Between Normal and Malignant Endometrial Tissue? N/A
Recruiting NCT03289468 - Study of Diagnosis of Color Power Doppler Combined Minimally Invasive Sampling for Endometrial Diseases
Completed NCT03755973 - Effect of Different Ovarian Stimulation Protocols on Endometrial Receptivity Phase 4
Withdrawn NCT04184323 - SIRT-1 Antagonism for Endometrial Receptivity Phase 2
Completed NCT06316206 - The Use of Ethinylestradiol/Dienogest in Random Start Rapid Endometrial Preparation Phase 4
Completed NCT06324851 - The Use of Drospirenone/Estetrol, Nomegestrol Acetate/Estradiol and Ethinylestradiol/Dienogest in Random Start Rapid Endometrial Preparation Phase 4
Completed NCT06316219 - The Use of Nomegestrol Acetate/Estradiol in Random Start Rapid Endometrial Preparation Phase 4
Completed NCT06316180 - The Use of Drospirenone/Estetrol in Random Start Rapid Endometrial Preparation Phase 4
Recruiting NCT06264921 - A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors Phase 1
Completed NCT03060603 - Proliferative Effects of Erythropoietin on Human Endometrium N/A
Completed NCT01808898 - Role of Intrauterine Cornual Block in Combination With Direct Cervical Block in Outpatient Endometrial Ablation Phase 4
Completed NCT05472740 - Transcutaneous Electrical Nerve Stimulation During Outpatient Endometrial Biopsy N/A
Completed NCT02716636 - Fast Versus Slow Tenaculum Placement N/A